Overall Status

Active, not recruiting (2)

Phase

phase 1 (1)

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (1)

OHSU Knight Cancer Institute (1)

Collaborator

Novartis Pharmaceuticals (1)

Oregon Health and Science University (1)

Intervention

laboratory biomarker analysis (2)

doxorubicin hydrochloride (1)

ipilimumab (1)

nivolumab (1)

pharmacological study (1)

quality-of-life assessment (1)

ribociclib (1)

Study Documents

Intervention Type

other (2)

biological (1)

drug (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

unresectable liposarcoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting

Advanced Soft Tissue Sarcoma
+26 more

Doxorubicin Hydrochloride
+3 more

Portland, Oregon

OHSU Knight Cancer Institute

Jan 6, 2023

Locally Advanced Bone Sarcoma, Locally Advanced Dedifferentiated Liposarcoma, Locally Advanced Gastrointestinal Stromal Tumor

Active, not recruiting

Has Results

Locally Advanced Bone Sarcoma
+20 more

Ipilimumab
+3 more

Anchorage, Alaska
+650 more

Oct 18, 2022